A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies. [electronic resource]

By: Contributor(s): Producer: 20070327Description: 727-31 p. digitalISSN:
  • 0090-8258
Subject(s): Online resources: In: Gynecologic oncology vol. 104
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.